Xtx Topco LTD Verve Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.72 Billion
- Q3 2025
A detailed history of Xtx Topco LTD transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 124,964 shares of VERV stock, worth $1.39 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
124,964
Previous 38,755
222.45%
Holding current value
$1.39 Million
Previous $435,000
219.54%
% of portfolio
0.08%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding VERV
# of Institutions
71Shares Held
29.7MCall Options Held
147KPut Options Held
440K-
Black Rock Inc. New York, NY6.62MShares$73.7 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL1.32MShares$14.6 Million0.0% of portfolio
-
Wade G W & Inc Wellesley, MA260KShares$2.89 Million0.12% of portfolio
-
Credit Suisse Ag Zurich, V865.7KShares$731,7080.0% of portfolio
-
Greenland Capital Management LP New York, NY49.5KShares$551,0010.06% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $667M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...